首页 > 最新文献

Indian Journal of Medical Microbiology最新文献

英文 中文
Meta-analysis of the diagnostic value of polymerase chain reaction-based nucleic acid detection methods for pertussis 聚合酶链反应核酸检测方法对百日咳诊断价值的meta分析
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.ijmmb.2025.101031
Fengyuan He , Limin Mei , Linzi Zeng

Introduction

Pertussis is an acute respiratory disease primarily caused by Bordetella pertussis, and its incidence has shown a resurgence. Polymerase chain reaction (PCR) is a recognized molecular detection method, and various related detection methods have emerged.

Methods

This study is performed according to the PRISMA checklist. Relevant literature is adopted from the online databases. The quality of the included studies is assessed based on the REVMAN software (version 5.4). Statistical analysis is performed by STATA 14.0 and Meta-DiSc 1.4 software.

Results

The results of this meta-analysis show that four different PCR techniques—conventional PCR, real-time quantitative PCR (Q-PCR), multiplex PCR, and nested PCR—have a pooled sensitivity of 0.95 (95 % CI: 0.93–0.97), pooled specificity of 0.93 (95 % CI: 0.89–0.95), pooled positive likelihood ratio (PLR) of 12.22 (95 % CI: 8.62–17.33), pooled negative likelihood ratio (NLR) of 0.05 (95 % CI: 0.03–0.08), and pooled diagnostic odds ratio (DOR) of 244.88 (95 % CI: 133.34–449.72). Multiplex PCR has the highest pooled specificity, PLR, and DOR. Nested PCR has the highest sensitivity and the lowest NLR. PCR testing holds significant value in the early diagnosis of pertussis. Multiplex PCR, nested PCR, and Q-PCR outperform conventional PCR in diagnostic performance.

Conclusions

Each type of PCR test has its advantages and disadvantages, and clinical selection should consider factors such as testing purpose, personnel, and conditions.
简介百日咳是一种主要由百日咳博德泰拉引起的急性呼吸道疾病,其发病率呈死灰复燃趋势。聚合酶链反应(Polymerase chain reaction, PCR)是一种公认的分子检测方法,相关的检测方法层出不穷。方法本研究按照PRISMA检查表进行。相关文献采用在线数据库。采用REVMAN软件(版本5.4)评估纳入研究的质量。采用STATA 14.0和Meta-DiSc 1.4软件进行统计分析。结果常规PCR、实时定量PCR (Q-PCR)、多重PCR和巢式PCR 4种不同PCR技术的合并敏感性为0.95 (95% CI: 0.93 ~ 0.97),合并特异性为0.93 (95% CI: 0.89 ~ 0.95),合并阳性似然比(PLR)为12.22 (95% CI: 8.62 ~ 17.33),合并阴性似然比(NLR)为0.05 (95% CI: 0.03 ~ 0.08),合并诊断优势比(DOR)为244.88 (95% CI: 133.34 ~ 449.72)。多重PCR具有最高的聚合特异性、PLR和DOR。巢式PCR的灵敏度最高,NLR最低。PCR检测对百日咳的早期诊断有重要价值。多重PCR、巢式PCR和Q-PCR在诊断性能上优于传统PCR。结论每种PCR检测方法各有优缺点,临床应综合考虑检测目的、人员、条件等因素进行选择。
{"title":"Meta-analysis of the diagnostic value of polymerase chain reaction-based nucleic acid detection methods for pertussis","authors":"Fengyuan He ,&nbsp;Limin Mei ,&nbsp;Linzi Zeng","doi":"10.1016/j.ijmmb.2025.101031","DOIUrl":"10.1016/j.ijmmb.2025.101031","url":null,"abstract":"<div><h3>Introduction</h3><div>Pertussis is an acute respiratory disease primarily caused by <em>Bordetella pertussis</em>, and its incidence has shown a resurgence. Polymerase chain reaction (PCR) is a recognized molecular detection method, and various related detection methods have emerged.</div></div><div><h3>Methods</h3><div>This study is performed according to the PRISMA checklist. Relevant literature is adopted from the online databases. The quality of the included studies is assessed based on the REVMAN software (version 5.4). Statistical analysis is performed by STATA 14.0 and Meta-DiSc 1.4 software.</div></div><div><h3>Results</h3><div>The results of this meta-analysis show that four different PCR techniques—conventional PCR, real-time quantitative PCR (Q-PCR), multiplex PCR, and nested PCR—have a pooled sensitivity of 0.95 (95 % CI: 0.93–0.97), pooled specificity of 0.93 (95 % CI: 0.89–0.95), pooled positive likelihood ratio (PLR) of 12.22 (95 % CI: 8.62–17.33), pooled negative likelihood ratio (NLR) of 0.05 (95 % CI: 0.03–0.08), and pooled diagnostic odds ratio (DOR) of 244.88 (95 % CI: 133.34–449.72). Multiplex PCR has the highest pooled specificity, PLR, and DOR. Nested PCR has the highest sensitivity and the lowest NLR. PCR testing holds significant value in the early diagnosis of pertussis. Multiplex PCR, nested PCR, and Q-PCR outperform conventional PCR in diagnostic performance.</div></div><div><h3>Conclusions</h3><div>Each type of PCR test has its advantages and disadvantages, and clinical selection should consider factors such as testing purpose, personnel, and conditions.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101031"},"PeriodicalIF":1.3,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic plasticity of Escherichia coli causing bloodstream infections in India: A focus on phylogroups A to F 引起印度血液感染的大肠杆菌的遗传可塑性:A到F系统群的焦点。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-22 DOI: 10.1016/j.ijmmb.2025.101026
Karthik Gunasekaran , Irulappan Madhumathi , Santhosh Raj , Greesma Grace Thomas , Venkatesh Narashiman , Vishnukumar Ramesh , Subbulakshmi Rajendran , Ramprakash Rayala , Ayyanraj Neeravi , Binesh Lal , Kamini Walia , Balaji Veeraraghavan

Background

Escherichia coli is a major pathogen in bloodstream infections (BSIs), with increasing concern over antimicrobial resistance (AMR) and the evolving pathogenic potential of phylogroups traditionally considered commensal. This study investigates the genetic characteristics of E. coli isolates causing BSIs in India, with a focus on phylogroups A to F.

Methods

204 E. coli bloodstream isolates received at a tertiary hospital in India were whole genome sequenced. Phylogroups, sequence types (STs), antimicrobial resistance genes (ARGs), virulence factors (VFs), and plasmid replicon types were determined. Bioinformatics analyses include MLST, ResFinder, VirulenceFinder, PlasmidFinder, and ClermonTyping for phylogroup assignment.

Results

Phylogroup B2 (35 %) was the most prevalent, followed by phylogroup A (32 %) and D (19 %). ST131 (B2) emerged as the dominant clone (22 %). Phylogroup A isolates, previously considered commensal and primarily associated with high AMR, now demonstrated notable acquisition of virulence factors such as fimH and iutA, indicating an emerging role as significant BSI pathogens. These isolates also showed high clonal diversity (e.g., ST167, ST410, ST617). Key resistance genes included blaCTX-M (53 %) and blaTEM (25 %), frequently associated with IncF plasmids. Multi-replicon plasmid profiles, particularly IncF variants, were significantly associated with co-carriage of both AMR and VF genes, contributing to enhanced pathogenicity.

Conclusion

This study highlights the emerging role of phylogroup A E. coli, traditionally commensal and AMR-rich as a leading cause of BSIs in India following the acquisition of virulence factors. In parallel, B2 clones like ST131 continue to drive infections through their established virulence and resistance repertoire. Such multi-replicon IncF plasmids driving AMR–VF co-selection, calls for focused surveillance and intervention in E. coli BSIs.
背景:大肠杆菌是血流感染(bsi)的主要病原体,人们越来越关注抗菌素耐药性(AMR)和传统上被认为是共生的系统群不断发展的致病潜力。本研究调查了印度引起bsi的大肠杆菌分离株的遗传特征,重点研究了系统群a至f。方法:对印度一家三级医院接收的204株大肠杆菌血液分离株进行了全基因组测序。测定系统群、序列型(STs)、耐药基因(ARGs)、毒力因子(VFs)和质粒复制子类型。生物信息学分析包括MLST, ResFinder, VirulenceFinder, PlasmidFinder和ClermonTyping用于系统群分配。结果:系统群B2(35%)最多,其次是系统群A(32%)和D(19%)。ST131 (B2)为优势克隆(22%)。系统群A分离物,以前被认为是共生的,主要与高AMR相关,现在显示出显著的毒力因子,如fimH和iutA,表明其作为重要BSI病原体的作用正在显现。这些分离株也表现出较高的克隆多样性(如ST167、ST410、ST617)。关键抗性基因包括blaCTX-M(53%)和blaTEM(25%),通常与IncF质粒相关。多复制子质粒谱,特别是IncF变异,与AMR和VF基因的共同携带显著相关,有助于增强致病性。结论:本研究强调了系统群A大肠杆菌的新作用,传统上是共生的,富含AMR,是获得毒力因子后印度bsi的主要原因。与此同时,像ST131这样的B2克隆继续通过其既定的毒力和抗性库驱动感染。这种多复制子IncF质粒驱动AMR-VF共选择,要求对大肠杆菌bsi进行重点监测和干预。
{"title":"Genetic plasticity of Escherichia coli causing bloodstream infections in India: A focus on phylogroups A to F","authors":"Karthik Gunasekaran ,&nbsp;Irulappan Madhumathi ,&nbsp;Santhosh Raj ,&nbsp;Greesma Grace Thomas ,&nbsp;Venkatesh Narashiman ,&nbsp;Vishnukumar Ramesh ,&nbsp;Subbulakshmi Rajendran ,&nbsp;Ramprakash Rayala ,&nbsp;Ayyanraj Neeravi ,&nbsp;Binesh Lal ,&nbsp;Kamini Walia ,&nbsp;Balaji Veeraraghavan","doi":"10.1016/j.ijmmb.2025.101026","DOIUrl":"10.1016/j.ijmmb.2025.101026","url":null,"abstract":"<div><h3>Background</h3><div><em>Escherichia coli</em> is a major pathogen in bloodstream infections (BSIs), with increasing concern over antimicrobial resistance (AMR) and the evolving pathogenic potential of phylogroups traditionally considered commensal. This study investigates the genetic characteristics of <em>E. coli</em> isolates causing BSIs in India, with a focus on phylogroups A to F.</div></div><div><h3>Methods</h3><div>204 <em>E. coli</em> bloodstream isolates received at a tertiary hospital in India were whole genome sequenced. Phylogroups, sequence types (STs), antimicrobial resistance genes (ARGs), virulence factors (VFs), and plasmid replicon types were determined. Bioinformatics analyses include MLST, ResFinder, VirulenceFinder, PlasmidFinder, and ClermonTyping for phylogroup assignment.</div></div><div><h3>Results</h3><div>Phylogroup B2 (35 %) was the most prevalent, followed by phylogroup A (32 %) and D (19 %). ST131 (B2) emerged as the dominant clone (22 %). Phylogroup A isolates, previously considered commensal and primarily associated with high AMR, now demonstrated notable acquisition of virulence factors such as <em>fimH</em> and <em>iutA</em>, indicating an emerging role as significant BSI pathogens. These isolates also showed high clonal diversity (e.g., ST167, ST410, ST617). Key resistance genes included blaCTX-M (53 %) and blaTEM (25 %), frequently associated with IncF plasmids. Multi-replicon plasmid profiles, particularly IncF variants, were significantly associated with co-carriage of both AMR and VF genes, contributing to enhanced pathogenicity.</div></div><div><h3>Conclusion</h3><div>This study highlights the emerging role of phylogroup A <em>E. coli</em>, traditionally commensal and AMR-rich as a leading cause of BSIs in India following the acquisition of virulence factors. In parallel, B2 clones like ST131 continue to drive infections through their established virulence and resistance repertoire. Such multi-replicon IncF plasmids driving AMR–VF co-selection, calls for focused surveillance and intervention in <em>E. coli</em> BSIs.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101026"},"PeriodicalIF":1.3,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out of Sight, Should not be out of mind: A perplexing case of Malaria 眼不见,心不应忘:一个令人困惑的疟疾病例。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-21 DOI: 10.1016/j.ijmmb.2025.101028
Shilpi Saxena , Reena Das , Sumeeta Khurana , Saleem Amjad Mirza , Kamal Deep Joshi , Harleen Kaur
Malaria diagnosis is often difficult in cases with low parasitaemia and atypical presentations. We report a 30-year-old male with high-grade fever, chills, and vomiting. At admission, he was afebrile, pale, and had progressive splenomegaly. Despite extensive investigations, including multiple peripheral blood smears and malaria rapid diagnostic tests, results were negative. Bone marrow examination revealed rare red blood cells with Plasmodium spp., confirmed by PCR from the marrow aspirate slide. He completely recovered after treatment with Artemether-Lumefantrine and Primaquine. This case underscores the value of bone marrow microscopy and PCR in diagnosing malaria in patients with unexplained cytopenias and splenomegaly.
在低寄生虫血症和非典型表现的病例中,疟疾诊断往往很困难。我们报告一名30岁男性患者出现高热、寒战和呕吐。入院时,他发热,脸色苍白,并有进行性脾大。尽管进行了广泛的调查,包括多次外周血涂片和疟疾快速诊断测试,但结果均为阴性。骨髓检查发现罕见的带有疟原虫的红细胞,经骨髓吸片PCR证实。经甲醚-氨苯曲明和伯氨喹治疗后完全康复。本病例强调了骨髓显微镜和PCR在诊断不明原因的细胞减少和脾肿大患者的疟疾中的价值。
{"title":"Out of Sight, Should not be out of mind: A perplexing case of Malaria","authors":"Shilpi Saxena ,&nbsp;Reena Das ,&nbsp;Sumeeta Khurana ,&nbsp;Saleem Amjad Mirza ,&nbsp;Kamal Deep Joshi ,&nbsp;Harleen Kaur","doi":"10.1016/j.ijmmb.2025.101028","DOIUrl":"10.1016/j.ijmmb.2025.101028","url":null,"abstract":"<div><div>Malaria diagnosis is often difficult in cases with low parasitaemia and atypical presentations. We report a 30-year-old male with high-grade fever, chills, and vomiting. At admission, he was afebrile, pale, and had progressive splenomegaly. Despite extensive investigations, including multiple peripheral blood smears and malaria rapid diagnostic tests, results were negative. Bone marrow examination revealed rare red blood cells with <em>Plasmodium</em> spp., confirmed by PCR from the marrow aspirate slide. He completely recovered after treatment with Artemether-Lumefantrine and Primaquine. This case underscores the value of bone marrow microscopy and PCR in diagnosing malaria in patients with unexplained cytopenias and splenomegaly.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101028"},"PeriodicalIF":1.3,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular epidemiology of human rhinovirus from clinical cases of Dibrugarh, Assam, India 印度阿萨姆邦迪布鲁加尔邦临床病例中人鼻病毒的分子流行病学研究
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-21 DOI: 10.1016/j.ijmmb.2025.101027
Mandakini Das , Biswajyoti Borkakoty , Nargis K. Bali , Neelanjana Sarmah , Aniruddha Jakharia , Rahul Hazarika , Chandrakanta Bhattacharya , Aktarul Islam Siddique , Kishore Sarma , Kimmi Sarmah , Harpreet Kaur

Purpose

Human rhinovirus (HRV), a member of the Enterovirus genus of the Picornaviridae family is a major respiratory pathogen and the leading cause of upper respiratory tract infections. Given the limited information on HRV prevalence and molecular epidemiology in Northeast India, this study investigated circulating HRV strains in the region from 2015 to 2018.

Methods

Nasopharyngeal and throat swab samples were collected and RNA was extracted for HRV detection using qRT-PCR. HRV-positive samples were subjected to bidirectional Sanger sequencing targeting the 549 bp VP4/VP2 region. Obtained sequences were aligned and analyzed phylogenetically using bioinformatics tools to determine genotype distribution and genetic diversity.

Results

Among 2642 cases, 354 (13.3 %) tested positive for HRV. HRV-C was the predominant species (48.7 %), followed by HRV-A (38.4 %) and HRV-B (7.6 %). HRV infection was significantly associated with lower respiratory symptoms such as cough (p < 0.001) and breathlessness (p < 0.026). The study identified 27 different HRV genotypes in the 39 sequenced samples, with HRV-C15 being the most common (9/39) overall and associated with disease severity (p = 0.003). Seasonality analysis indicated peak HRV circulation between August and November (48.8 %, 173/354), with the lowest detected in June–July (14.1 %). HRV-C was more frequently observed in severe acute respiratory infection (SARI) cases and demonstrated the highest heterogeneity, with an intra-species nucleotide mean p-distance of 24.0 %.

Conclusion

In conclusion, this study presents the first report on the prevalence of human rhinovirus (HRV) among influenza-like illness (ILI) cases in Dibrugarh, Assam, India. HRV-C exhibited distinct epidemiological characteristics compared to HRV-A and HRV-B strains. Molecular epidemiological analysis revealed notable nucleotide variation in the VP4/VP2 region, with HRV-C15 emerging as the predominant genotype associated with increased disease severity. Further research involving larger sample sizes and detailed clinical follow-up is essential to better understand the genotype distribution and genetic diversity of HRV strains circulating in the region.
目的:人鼻病毒(HRV)是小核糖核酸病毒科肠病毒属的一员,是一种主要的呼吸道病原体,是上呼吸道感染的主要原因。鉴于印度东北部HRV患病率和分子流行病学信息有限,本研究调查了2015年至2018年该地区流行的HRV菌株。方法:采集鼻咽和咽拭子标本,提取RNA,采用qRT-PCR检测HRV。hrv阳性样本针对549 bp VP4/VP2区域进行双向Sanger测序。利用生物信息学工具对获得的序列进行比对和系统发育分析,以确定基因型分布和遗传多样性。结果:2642例中,HRV阳性354例(13.3%)。HRV-C是优势种(48.7%),其次是HRV-A(38.4%)和HRV-B(7.6%)。HRV感染与咳嗽等下呼吸道症状显著相关(结论:本研究首次报道了印度阿萨姆邦迪布鲁加尔省流感样疾病(ILI)病例中人鼻病毒(HRV)的流行情况。与HRV-A和HRV-B株相比,HRV-C株具有明显的流行病学特征。分子流行病学分析显示VP2/VP4区域的核苷酸显著变异,HRV-C15成为与疾病严重程度增加相关的主要基因型。为了更好地了解该地区流行的HRV毒株的基因型分布和遗传多样性,需要开展更大样本量和详细临床随访的进一步研究。
{"title":"Molecular epidemiology of human rhinovirus from clinical cases of Dibrugarh, Assam, India","authors":"Mandakini Das ,&nbsp;Biswajyoti Borkakoty ,&nbsp;Nargis K. Bali ,&nbsp;Neelanjana Sarmah ,&nbsp;Aniruddha Jakharia ,&nbsp;Rahul Hazarika ,&nbsp;Chandrakanta Bhattacharya ,&nbsp;Aktarul Islam Siddique ,&nbsp;Kishore Sarma ,&nbsp;Kimmi Sarmah ,&nbsp;Harpreet Kaur","doi":"10.1016/j.ijmmb.2025.101027","DOIUrl":"10.1016/j.ijmmb.2025.101027","url":null,"abstract":"<div><h3>Purpose</h3><div>Human rhinovirus (HRV), a member of the <em>Enterovirus</em> genus of the <em>Picornaviridae</em> family is a major respiratory pathogen and the leading cause of upper respiratory tract infections. Given the limited information on HRV prevalence and molecular epidemiology in Northeast India, this study investigated circulating HRV strains in the region from 2015 to 2018.</div></div><div><h3>Methods</h3><div>Nasopharyngeal and throat swab samples were collected and RNA was extracted for HRV detection using qRT-PCR. HRV-positive samples were subjected to bidirectional Sanger sequencing targeting the 549 bp VP4/VP2 region. Obtained sequences were aligned and analyzed phylogenetically using bioinformatics tools to determine genotype distribution and genetic diversity.</div></div><div><h3>Results</h3><div>Among 2642 cases, 354 (13.3 %) tested positive for HRV. HRV-C was the predominant species (48.7 %), followed by HRV-A (38.4 %) and HRV-B (7.6 %). HRV infection was significantly associated with lower respiratory symptoms such as cough (p &lt; 0.001) and breathlessness (p &lt; 0.026). The study identified 27 different HRV genotypes in the 39 sequenced samples, with HRV-C15 being the most common (9/39) overall and associated with disease severity (p = 0.003). Seasonality analysis indicated peak HRV circulation between August and November (48.8 %, 173/354), with the lowest detected in June–July (14.1 %). HRV-C was more frequently observed in severe acute respiratory infection (SARI) cases and demonstrated the highest heterogeneity, with an intra-species nucleotide mean p-distance of 24.0 %.</div></div><div><h3>Conclusion</h3><div>In conclusion, this study presents the first report on the prevalence of human rhinovirus (HRV) among influenza-like illness (ILI) cases in Dibrugarh, Assam, India. HRV-C exhibited distinct epidemiological characteristics compared to HRV-A and HRV-B strains. Molecular epidemiological analysis revealed notable nucleotide variation in the VP4/VP2 region, with HRV-C15 emerging as the predominant genotype associated with increased disease severity. Further research involving larger sample sizes and detailed clinical follow-up is essential to better understand the genotype distribution and genetic diversity of HRV strains circulating in the region.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101027"},"PeriodicalIF":1.3,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A molecular snapshot of clinical extra-intestinal Escherichia coli strains in South India – Virulence factors, phylogrouping and resistance trends 南印度临床肠外大肠杆菌菌株的分子快照-毒力因素,系统分组和耐药趋势。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.ijmmb.2025.101024
Thripthi Ananda , Chiranjay Mukhopadhyay

Introduction

E. coli is a frequently encountered clinical pathogen, and periodic monitoring of antimicrobial resistance and virulence profiles is crucial for defining roadmaps for both infection prevention and control practices.

Objective

We aimed to compare the proportions of key phylogenetic groups, virulence associated genes (VAGs), and antimicrobial susceptibility (AST) patterns of E. coli isolated from various clinical samples and compare expression levels of key VAGs in patients with uncomplicated UTI versus those with UTI + bacteraemia in a tertiary-care hospital in South India.

Methods

Clinical E. coli isolates, confirmed using the MALDI-TOF MS, and satisfying the National Healthcare Safety Network(NHSN) criteria for infections were included. Phylogenetic grouping and VAGs detection were performed using multiplex-PCR and targeted gene expression was carried out using quantitative RT-qPCR. AST was determined using VITEK 2 system.

Results

The included 288E. coli isolates (144 from bacteraemia and non-bacteraemia cases each) predominately showed phylogroup B2 (52 %), followed by D (23 %), and most prevalent virulence genes were chuA (74.7 %), fimH(63.3 %), traT(63.2 %), and kpsMTII(54.2 %). fimH, fyuA, and hlyD were significantly associated with bacteraemia, and gene expression of these genes and the analysis demonstrated that hlyD expression was significantly higher (p = 0.012) in UTI + bacteraemia patients when compared to patients with uncomplicated UTI. Phylogroup B2 carried the highest median number of VAGs (7), followed by D (6). Highest susceptibility was towards tigecycline (99.7 %), followed by amikacin (91.7 %) and meropenem (90.0 %).

Conclusion

We focused on prevalent virulent genes and their expression, leading to bacteraemia, providing a comprehensive overview of an existing concern. Focusing on bacterial gene expression along with integrated surveillance of antimicrobial resistance helps in designing further research so that strategies can be planned that will later help in early risk stratification and informed clinical decision-making to prevent severe complications including secondary bacteraemia and other severe patient morbidities.
简介:大肠杆菌是一种常见的临床病原体,定期监测抗菌素耐药性和毒力谱对于确定感染预防和控制实践的路线图至关重要。目的:我们旨在比较从不同临床样本中分离的大肠杆菌的关键系统发育群、毒力相关基因(VAGs)和抗菌敏感性(AST)模式的比例,并比较印度南部一家三级医院中无并发症尿路感染患者和尿路感染+菌血症患者关键VAGs的表达水平。方法:纳入经MALDI-TOF MS确证并符合国家医疗安全网络(NHSN)感染标准的临床分离的大肠杆菌。采用多重pcr进行系统发育分组和VAGs检测,采用定量RT-qPCR进行靶向基因表达。AST采用VITEK 2系统测定。结果:288株大肠杆菌(菌血症和非菌血症各144株)以系统群B2(52%)为主,其次是D(23%),常见的毒力基因为chuA(74.7%)、fimH(63.3%)、traT(63.2%)和kpsMTII(54.2%)。fimH、fyuA和hlyD与菌血症有显著相关性,分析表明UTI+菌血症患者的基因表达和hlyD的表达均显著高于单纯UTI患者(p = 0.012)。系统类群B2中位VAGs数最多(7个),D次之(6个)。对替加环素的敏感性最高(99.7%),其次是阿米卡星(91.7%)和美罗培南(90.0%)。结论:我们关注的是导致菌血症的流行毒力基因及其表达,提供了对现有问题的全面概述。关注细菌基因表达以及对抗菌素耐药性的综合监测有助于设计进一步的研究,以便制定策略,随后有助于早期风险分层和知情的临床决策,以预防严重并发症,包括继发性菌血症和其他严重的患者发病率。
{"title":"A molecular snapshot of clinical extra-intestinal Escherichia coli strains in South India – Virulence factors, phylogrouping and resistance trends","authors":"Thripthi Ananda ,&nbsp;Chiranjay Mukhopadhyay","doi":"10.1016/j.ijmmb.2025.101024","DOIUrl":"10.1016/j.ijmmb.2025.101024","url":null,"abstract":"<div><h3>Introduction</h3><div><em>E. coli</em> is a frequently encountered clinical pathogen, and periodic monitoring of antimicrobial resistance and virulence profiles is crucial for defining roadmaps for both infection prevention and control practices.</div></div><div><h3>Objective</h3><div>We aimed to compare the proportions of key phylogenetic groups, virulence associated genes (VAGs), and antimicrobial susceptibility (AST) patterns of <em>E. coli</em> isolated from various clinical samples and compare expression levels of key VAGs in patients with uncomplicated UTI versus those with UTI + bacteraemia in a tertiary-care hospital in South India.</div></div><div><h3>Methods</h3><div>Clinical <em>E. coli</em> isolates, confirmed using the MALDI-TOF MS, and satisfying the National Healthcare Safety Network(NHSN) criteria for infections were included. Phylogenetic grouping and VAGs detection were performed using multiplex-PCR and targeted gene expression was carried out using quantitative RT-qPCR. AST was determined using VITEK 2 system.</div></div><div><h3>Results</h3><div>The included 288<em>E. coli</em> isolates (144 from bacteraemia and non-bacteraemia cases each) predominately showed phylogroup B2 (52 %), followed by D (23 %), and most prevalent virulence genes were <em>chuA</em> (74.7 %), <em>fimH</em>(63.3 %), <em>traT</em>(63.2 %), and <em>kpsMTII</em>(54.2 %). <em>fimH, fyuA</em>, and <em>hlyD</em> were significantly associated with bacteraemia, and gene expression of these genes and the analysis demonstrated that <em>hlyD</em> expression was significantly higher (<em>p</em> = 0.012) in UTI + bacteraemia patients when compared to patients with uncomplicated UTI. Phylogroup B2 carried the highest median number of VAGs (7), followed by D (6). Highest susceptibility was towards tigecycline (99.7 %), followed by amikacin (91.7 %) and meropenem (90.0 %).</div></div><div><h3>Conclusion</h3><div>We focused on prevalent virulent genes and their expression, leading to bacteraemia, providing a comprehensive overview of an existing concern. Focusing on bacterial gene expression along with integrated surveillance of antimicrobial resistance helps in designing further research so that strategies can be planned that will later help in early risk stratification and informed clinical decision-making to prevent severe complications including secondary bacteraemia and other severe patient morbidities.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101024"},"PeriodicalIF":1.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular characterisation of fosfomycin resistant Enterococci faecalis isolated from a tertiary care medical hospital in northern India 从印度北部一家三级医疗医院分离的耐磷霉素粪肠球菌的分子特征
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.ijmmb.2025.101022
Anjum Ara Mir, Sayim Wani, Nargis Bali, Bisma Ahad, Masooma Showkat, Aarifa Bashir

Purpose

To evaluate the in-vitro activity of fosfomycin in urinary isolates of Enterococcus faecalis and look for the molecular mechanisms responsible for resistance to this antibiotic.

Methods

E. faecalis isolates recovered from urine samples were processed for the presence of genes encoding the FOS modifying enzymes, fosA, fosB, fosC, fosX and murA. DNA was extracted using QIAamp DNA Mini kit. Conventional PCR using forward and reverse primers targeting the five genes was carried out. The amplified products were electrophoresed and visualized in a gel documentation system. Antimicrobial susceptibility testing was done by disc diffusion method.

Results

A total of 274 isolates of E. faecalis isolates were part of our study out of which 57 (20.8 %) were FOS resistant. Slightly more number of FOS resistant isolates were recovered from female patients, 30 (52.6 %) and from patients in the age group of >39 yrs. Majority of the FOS resistant isolates were recovered from patients attending the OPD. Vancomycin resistance was seen in 69 (25.2 %) E. faecalis isolates. fosB was was the most common gene, present in 42 (73.7 %) isolates and murA was present in 15 (26.3 %) isolates of E. faecalis. Furthermore all the FOS resistant, vancomycin resistant isolates harboured the fosB gene (n = 26).

Conclusion

To our knowledge this study is the first to explore FOS resistance in E. faecalis isolates from this part of the country. Increased resistance to FOS as compared to what has been reported previously calls for strict implementation of infection control protocols as well as heightened surveillance studies.
目的:评价尿路分离的粪肠球菌对磷霉素的体外活性,探讨其耐药的分子机制。方法:对尿液中分离的粪肠球菌进行FOS修饰酶基因fosA、fosB、fosC、fox和murA的检测。采用QIAamp DNA Mini试剂盒提取DNA。对这5个基因分别采用正、反向引物进行常规PCR。扩增产物在凝胶记录系统中电泳和可视化。药敏试验采用纸片扩散法。结果:本研究共分离到274株粪肠球菌,其中57株(20.8%)对FOS耐药。从女性患者中分离出的FOS耐药菌株数量略多,为30株(52.6%),从bb0 ~ 39岁年龄组的患者中分离出FOS耐药菌株。大多数FOS耐药分离株是从门诊就诊的患者中恢复的。69株(25.2%)粪肠球菌对万古霉素耐药。fosB是最常见的基因,在42株(73.7%)中存在,murA在15株(26.3%)中存在。此外,所有FOS耐药、万古霉素耐药分离株均含有fosB基因(n=26)。结论:据我们所知,本研究首次探讨了该地区粪伊蚊对FOS的耐药性。与以前报告的情况相比,FOS耐药性的增加要求严格执行感染控制方案并加强监测研究。
{"title":"Molecular characterisation of fosfomycin resistant Enterococci faecalis isolated from a tertiary care medical hospital in northern India","authors":"Anjum Ara Mir,&nbsp;Sayim Wani,&nbsp;Nargis Bali,&nbsp;Bisma Ahad,&nbsp;Masooma Showkat,&nbsp;Aarifa Bashir","doi":"10.1016/j.ijmmb.2025.101022","DOIUrl":"10.1016/j.ijmmb.2025.101022","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the in-vitro activity of fosfomycin in urinary isolates of <em>Enterococcus faecalis</em> and look for the molecular mechanisms responsible for resistance to this antibiotic.</div></div><div><h3>Methods</h3><div><em>E. faecalis</em> isolates recovered from urine samples were processed for the presence of genes encoding the FOS modifying enzymes, <em>fosA, fosB, fosC, fosX</em> and <em>murA</em>. DNA was extracted using QIAamp DNA Mini kit. Conventional PCR using forward and reverse primers targeting the five genes was carried out. The amplified products were electrophoresed and visualized in a gel documentation system. Antimicrobial susceptibility testing was done by disc diffusion method.</div></div><div><h3>Results</h3><div>A total of 274 isolates of <em>E. faecalis</em> isolates were part of our study out of which 57 (20.8 %) were FOS resistant. Slightly more number of FOS resistant isolates were recovered from female patients, 30 (52.6 %) and from patients in the age group of &gt;39 yrs. Majority of the FOS resistant isolates were recovered from patients attending the OPD. Vancomycin resistance was seen in 69 (25.2 %) <em>E. faecalis</em> isolates. <em>fosB</em> was was the most common gene, present in 42 (73.7 %) isolates and <em>murA</em> was present in 15 (26.3 %) isolates of <em>E. faecalis</em>. Furthermore all the FOS resistant, vancomycin resistant isolates harboured the <em>fosB</em> gene (n = 26).</div></div><div><h3>Conclusion</h3><div>To our knowledge this study is the first to explore FOS resistance in <em>E. faecalis</em> isolates from this part of the country. Increased resistance to FOS as compared to what has been reported previously calls for strict implementation of infection control protocols as well as heightened surveillance studies.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101022"},"PeriodicalIF":1.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole-genome sequence analysis of cefiderocol-resistant E. coli and Klebsiella pneumoniae isolates from cefiderocol treatment-naïve patients 头孢地罗Treatment-Naïve患者耐药大肠杆菌和肺炎克雷伯菌全基因组序列分析。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.ijmmb.2025.101025
Gayatree Nayak , Naveen Kumar Devanga Ragupathi , Bijayini Behera
Cefiderocol (FDC) is regarded as a reserved therapeutic option for serious CRE infections. In an earlier study, we had reported a 9.9 % FDC resistance in CRE isolates. In the present study, we are reporting the whole genome sequencing analysis findings of two FDC-resistant CRE (One E. coli and one K. pneumoniae). PBP3 insertions and mutations in the siderophore receptor cirA were the primary drivers of FDC resistance in E. coli. In K. pneumoniae, there was intact porin and a single copy of blaNDM-5, and a combination of β-lactamase and carbapenem resistance genes, including blaTEM- 1B, blaCTX-M-15, blaNDM-5 and blaOXA-181.
头孢地罗(FDC)被认为是严重CRE感染的保留治疗选择。在早期的一项研究中,我们报道了CRE分离株9.9%的FDC耐药性。在本研究中,我们报告了两种耐药CRE(一种大肠杆菌和一种肺炎克雷伯菌)的全基因组测序分析结果。铁载体受体cirA中的PBP3插入和突变是大肠杆菌FDC耐药的主要驱动因素。在肺炎克雷伯菌中,存在完整的孔蛋白和单拷贝blaNDM-5,以及β-内酰胺酶和碳青霉烯类耐药基因blandm - 1B、blaCTX-M-15、blaNDM-5和blaOXA-181的组合。
{"title":"Whole-genome sequence analysis of cefiderocol-resistant E. coli and Klebsiella pneumoniae isolates from cefiderocol treatment-naïve patients","authors":"Gayatree Nayak ,&nbsp;Naveen Kumar Devanga Ragupathi ,&nbsp;Bijayini Behera","doi":"10.1016/j.ijmmb.2025.101025","DOIUrl":"10.1016/j.ijmmb.2025.101025","url":null,"abstract":"<div><div>Cefiderocol (FDC) is regarded as a reserved therapeutic option for serious CRE infections. In an earlier study, we had reported a 9.9 % FDC resistance in CRE isolates. In the present study, we are reporting the whole genome sequencing analysis findings of two FDC-resistant CRE (One <em>E. coli</em> and one <em>K. pneumoniae</em>). PBP3 insertions and mutations in the siderophore receptor <em>cirA</em> were the primary drivers of FDC resistance in <em>E. coli</em>. In <em>K. pneumoniae</em>, there was intact porin and a single copy of <em>bla</em><sub>NDM-5</sub>, and a combination of β-lactamase and carbapenem resistance genes, including <em>bla</em><sub>TEM- 1B</sub>, <em>bla</em><sub>CTX-M-15,</sub> <em>bla</em><sub>NDM-5</sub> and <em>bla</em><sub>OXA-181</sub>.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101025"},"PeriodicalIF":1.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance in blood culture proven sepsis in outborn and inborn neonates 血液培养中的抗菌素耐药性证实了先天性和先天性新生儿的败血症。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.ijmmb.2025.101023
Alisha Mahajan , Varsha Gupta , Suksham Jain

Background

Neonatal sepsis is a major cause of mortality and morbidity, representing a critical emergency that demands swift diagnosis and intervention. Recent trend shows increasing resistance to commonly used antibiotics.

Aims and objectives

To study the antimicrobial resistance pattern in blood culture positive neonatal sepsis in outborn and inborn neonates and to compare the clinical profile in neonates with proven sepsis.

Methods

Bacterial cultures of the blood samples received from neonates with suspected sepsis was performed and antimicrobial susceptibility testing of blood culture positive neonates was done. Antibiotic sensitivity tests were done as per Clinical and Laboratory Standards Institute (CLSI) 2023 guidelines.

Results

Of the 100 participants, 34 were early onset neonatal sepsis and 66 were late onset neonatal sepsis. 35 % of the delivery were vaginal whereas 65 % of the deliveries were by Caesarean section. 17 % of the total neonates delivered had to undergo neonatal resuscitation and 36 % of the neonates had birth asphyxia. The most commonly isolated organisms were Coagulase-negative Staphylococcus species (CoNS) (30 %) followed by Klebsiella pneumoniae (21 %) and Acinetobacter baumannii complex (20 %). 45.1 % were Extended Spectrum beta lactamase (ESBL) producers and 58 % were AmpC beta lactamases producers.
Case fatality rate was highest with Klebsiella pneumoniae i.e. 34.6 % followed by Acinetobacter baumannii complex i.e. 23.07 %.

Conclusion

Increase in antibiotic resistance organisms can lead to an increase in the neonatal case fatality rate (CFR), so regular surveillance is needed. Comparison between the resistance profile between inborn and outborn neonates provides an insight into the difference in the variety of organisms isolated and also the difference in resistance shown by community acquired and hospital acquired organisms.
背景:新生儿败血症是死亡率和发病率的主要原因,是一种需要迅速诊断和干预的紧急情况。最近的趋势表明,对常用抗生素的耐药性正在增加。目的和目的:研究血培养阳性新生儿败血症和出生新生儿的抗菌药物耐药模式,并比较证实败血症的新生儿的临床资料。方法:对疑似脓毒症患儿血液标本进行细菌培养,对血培养阳性患儿进行药敏试验。抗生素敏感性测试按照临床和实验室标准协会(CLSI) 2023指南进行。结果:在100名参与者中,34名为早发型新生儿脓毒症,66名为晚发型新生儿脓毒症。35%的分娩是阴道分娩,65%的分娩是剖腹产。17%的新生儿需要进行新生儿复苏,36%的新生儿出现出生窒息。最常见的分离菌是凝固酶阴性葡萄球菌(con)(30%),其次是肺炎克雷伯菌(21%)和鲍曼不动杆菌复合体(20%)。45.1%为扩展谱β -内酰胺酶(ESBL)产生菌,58%为AmpC β -内酰胺酶产生菌。肺炎克雷伯菌病死率最高,为34.6%,其次是鲍曼复合不动杆菌,病死率为23.07%。结论:抗生素耐药菌的增加可导致新生儿病死率(CFR)的增加,因此需要定期监测。比较先天和外生新生儿的耐药情况,可以深入了解分离出的微生物种类的差异,以及社区获得性和医院获得性微生物所表现出的耐药差异。
{"title":"Antimicrobial resistance in blood culture proven sepsis in outborn and inborn neonates","authors":"Alisha Mahajan ,&nbsp;Varsha Gupta ,&nbsp;Suksham Jain","doi":"10.1016/j.ijmmb.2025.101023","DOIUrl":"10.1016/j.ijmmb.2025.101023","url":null,"abstract":"<div><h3>Background</h3><div>Neonatal sepsis is a major cause of mortality and morbidity, representing a critical emergency that demands swift diagnosis and intervention. Recent trend shows increasing resistance to commonly used antibiotics.</div></div><div><h3>Aims and objectives</h3><div>To study the antimicrobial resistance pattern in blood culture positive neonatal sepsis in outborn and inborn neonates and to compare the clinical profile in neonates with proven sepsis.</div></div><div><h3>Methods</h3><div>Bacterial cultures of the blood samples received from neonates with suspected sepsis was performed and antimicrobial susceptibility testing of blood culture positive neonates was done. Antibiotic sensitivity tests were done as per Clinical and Laboratory Standards Institute (CLSI) 2023 guidelines.</div></div><div><h3>Results</h3><div>Of the 100 participants, 34 were early onset neonatal sepsis and 66 were late onset neonatal sepsis. 35 % of the delivery were vaginal whereas 65 % of the deliveries were by Caesarean section. 17 % of the total neonates delivered had to undergo neonatal resuscitation and 36 % of the neonates had birth asphyxia. The most commonly isolated organisms were Coagulase-negative Staphylococcus species (CoNS) (30 %) followed by <em>Klebsiella pneumoniae</em> (21 %) and <em>Acinetobacter baumannii complex</em> (20 %). 45.1 % were Extended Spectrum beta lactamase (ESBL) producers and 58 % were AmpC beta lactamases producers.</div><div>Case fatality rate was highest with <em>Klebsiella pneumoniae</em> i.e. 34.6 % followed by <em>Acinetobacter baumannii complex</em> i.e. 23.07 %.</div></div><div><h3>Conclusion</h3><div>Increase in antibiotic resistance organisms can lead to an increase in the neonatal case fatality rate (CFR), so regular surveillance is needed. Comparison between the resistance profile between inborn and outborn neonates provides an insight into the difference in the variety of organisms isolated and also the difference in resistance shown by community acquired and hospital acquired organisms.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101023"},"PeriodicalIF":1.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of Xpert MTB/RIF Ultra for abdominal tuberculosis in a tertiary care setting in North India 专家MTB/RIF Ultra在印度北部三级医疗机构诊断腹部结核病的准确性。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-12 DOI: 10.1016/j.ijmmb.2025.101008
Anuj Pathak , Reena Raveendran , Jaswinder Kaur Oberoi , Chand Wattal , Anil Arora , Vikas Singla

Background

Abdominal tuberculosis (TB) poses diagnostic difficulties due to its vague symptoms and low bacterial load. Culture, the gold standard, is limited by a prolonged turnaround time of up to eight weeks. Xpert MTB/RIF Ultra (Xpert Ultra), a rapid, automated molecular test, can detect Mycobacterium tuberculosis and rifampicin resistance in under two hours. This study evaluated the diagnostic accuracy of Xpert Ultra for abdominal TB using both culture and a composite reference standard (CRS), and assessed its agreement in rifampicin resistance detection with phenotypic and genotypic drug susceptibility testing (DST).

Methods

A prospective observational study was conducted from September 2019 to March 2021 at a tertiary care centre in North India. Adults with clinical and radiological features of abdominal TB were enrolled. Relevant abdominal samples were collected and tested using smear, culture (BACTEC MGIT 960), Xpert Ultra, histopathology, and clinical response. Rifampicin resistance was confirmed using MGIT 960 and GenoType MTBDRplus.

Results

Of 176 eligible patients, 144 were enrolled, yielding 152 abdominal samples: lymph node aspirates (52%), biopsies (42.8%), pus/aspirates (3.3%), and ascitic/omental fluids (2%). Xpert Ultra showed 84% diagnostic accuracy against CRS and 75% against culture. Rifampicin resistance detection showed 100% concordance with both phenotypic and genotypic DST.

Conclusion

Xpert Ultra offers high diagnostic accuracy and excellent concordance in rifampicin resistance detection for abdominal TB. Its speed and reliability make it a valuable diagnostic tool in high-burden settings.
背景:腹部结核(TB)由于其症状模糊和细菌负荷低而造成诊断困难。文化作为黄金标准,受到长达8周的长时间周转时间的限制。Xpert MTB/RIF Ultra (Xpert Ultra)是一种快速、自动化的分子检测方法,可在两小时内检测出结核分枝杆菌和利福平耐药性。本研究通过培养和综合参考标准(CRS)评估Xpert Ultra对腹部结核的诊断准确性,并评估其在利福平耐药检测与表型和基因型药敏试验(DST)的一致性。方法:2019年9月至2021年3月在印度北部的一家三级保健中心进行了一项前瞻性观察研究。有腹部结核临床和放射学特征的成年人被纳入研究。收集相关腹部样本,并使用涂片、培养(BACTEC MGIT 960)、Xpert Ultra、组织病理学和临床反应进行检测。使用MGIT 960和基因型MTBDRplus确认利福平耐药。结果:在176名符合条件的患者中,144名入组,获得152份腹部样本:淋巴结抽吸(52%),活检(42.8%),脓液/抽吸(3.3%)和腹水/大网膜液体(2%)。Xpert Ultra对CRS的诊断准确率为84%,对culture的诊断准确率为75%。利福平耐药检测结果与表型和基因型DST的一致性均为100%。结论:Xpert Ultra对腹部结核利福平耐药检测具有较高的诊断准确性和良好的一致性。它的速度和可靠性使其成为高负荷环境中有价值的诊断工具。
{"title":"Diagnostic accuracy of Xpert MTB/RIF Ultra for abdominal tuberculosis in a tertiary care setting in North India","authors":"Anuj Pathak ,&nbsp;Reena Raveendran ,&nbsp;Jaswinder Kaur Oberoi ,&nbsp;Chand Wattal ,&nbsp;Anil Arora ,&nbsp;Vikas Singla","doi":"10.1016/j.ijmmb.2025.101008","DOIUrl":"10.1016/j.ijmmb.2025.101008","url":null,"abstract":"<div><h3>Background</h3><div>Abdominal tuberculosis (TB) poses diagnostic difficulties due to its vague symptoms and low bacterial load. Culture, the gold standard, is limited by a prolonged turnaround time of up to eight weeks. Xpert MTB/RIF Ultra (Xpert Ultra), a rapid, automated molecular test, can detect Mycobacterium tuberculosis and rifampicin resistance in under two hours. This study evaluated the diagnostic accuracy of Xpert Ultra for abdominal TB using both culture and a composite reference standard (CRS), and assessed its agreement in rifampicin resistance detection with phenotypic and genotypic drug susceptibility testing (DST).</div></div><div><h3>Methods</h3><div>A prospective observational study was conducted from September 2019 to March 2021 at a tertiary care centre in North India. Adults with clinical and radiological features of abdominal TB were enrolled. Relevant abdominal samples were collected and tested using smear, culture (BACTEC MGIT 960), Xpert Ultra, histopathology, and clinical response. Rifampicin resistance was confirmed using MGIT 960 and GenoType MTBDRplus.</div></div><div><h3>Results</h3><div>Of 176 eligible patients, 144 were enrolled, yielding 152 abdominal samples: lymph node aspirates (52%), biopsies (42.8%), pus/aspirates (3.3%), and ascitic/omental fluids (2%). Xpert Ultra showed 84% diagnostic accuracy against CRS and 75% against culture. Rifampicin resistance detection showed 100% concordance with both phenotypic and genotypic DST.</div></div><div><h3>Conclusion</h3><div>Xpert Ultra offers high diagnostic accuracy and excellent concordance in rifampicin resistance detection for abdominal TB. Its speed and reliability make it a valuable diagnostic tool in high-burden settings.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101008"},"PeriodicalIF":1.3,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145523285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent MALDI-TOF MS identification failure for Sphingomonas paucimobilis from blood cultures: A single-center observation 血液培养中反复MALDI-TOF质谱鉴定少动鞘氨单胞菌失败:单中心观察。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.ijmmb.2025.101009
Shikhir Malhotra, Vibhor Tak
{"title":"Recurrent MALDI-TOF MS identification failure for Sphingomonas paucimobilis from blood cultures: A single-center observation","authors":"Shikhir Malhotra,&nbsp;Vibhor Tak","doi":"10.1016/j.ijmmb.2025.101009","DOIUrl":"10.1016/j.ijmmb.2025.101009","url":null,"abstract":"","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101009"},"PeriodicalIF":1.3,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1